Icosagen Therapeutics

Icosagen is a research-driven biotechnology company based in Estonia that specializes in the discovery and development of therapeutic antibodies and recombinant proteins. The company operates through a dual business model, providing contract research and manufacturing services (CRO/CDMO) while advancing its own internal pipeline of biotherapeutics. Icosagen utilizes its proprietary QMCF and IcoCell platforms to streamline the production of complex proteins and stable mammalian cell lines. Their therapeutic focus primarily spans oncology and infectious diseases, supported by a newly established GMP manufacturing facility that enables the production of clinical-grade biologics.